TY - JOUR AU - Esther Yu AU - Muhammad Saif AU - Kathryn Huber PY - 2014/07/28 Y2 - 2024/03/28 TI - Phase 1 Trials in Pancreatic Cancer JF - JOP. Journal of the Pancreas JA - JOP VL - 15 IS - 4 SE - Highlights from the “50th ASCO Annual Meeting 2014”. Chicago, IL, USA. May 30 - June 3, 2014 DO - 10.6092/1590-8577/2683 UR - http://www.serena.unina.it/index.php/jop/article/view/2683 AB - Despite many clinical trials over the last two decades since the approval of gemcitabine, the survival of patients with pancreatic cancer has improved by a few only months. This disappointing reality underlines an urgent need to develop more effective drugs or better combinations. A variety of phase I trials were presented at the annual meeting of ASCO 2014 focusing on locally advanced and metastatic pancreatic cancer. We summarize four abstracts (abstracts #4116, #4123, #4026, #4138).Image: Radiation Oncology, Tufts Medical Center. Boston, MA, USA. ER -